Context Therapeutics Inc. — Director's Dealing 2021

Oct 20, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Context Therapeutics Inc. (CNTX)
CIK: 0001842952
Period of Report: 2021-10-19

Reporting Person: Lehr Martin A. (Director, Chief Executive Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	89583	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Series A Preferred Stock	$		Common Stock (210722)		Indirect
Series Seed Preferred Stock	$		Common Stock (586476)		Indirect
Warrant (right to buy)	$7.14	2030-12-20	Common Stock (52680)		Indirect
Stock Option (right to buy)	$4.94	2031-04-30	Common Stock (281354)		Direct

Footnotes

F1: Exercisable upon the date of grant.

F2: N/A

F3: Converts to common stock on a one for one basis.

F4: The stock option vests each month (1/36 each month) from the date of the grant, April 30, 2021.